TABLE 1.

Correlation between mSREBP1‐symmetric dimethyl arginine (SDMA) and Ser473‐phosphorylated protein kinase B (AKT‐473P) levels with other clinicopathological characteristics in 102 lung adenocarcinomas

Variable	Number	mSREBP1‐SDMA			AKT‐473P
		Low expression	High expression	P value	Low expression	High expression	P value
Age (y)
≤60	52	20	32		26	26
>60	50	27	23	.116	25	25	1.000
Gender
Female	46	25	21		27	19
Male	56	22	34	.129	24	32	.111
Smoking history
Yes	47	25	22		27	20
No	55	21	34	.104	24	31	.164
Tumor location
Left	31	17	14		20	11
Right	71	30	41	.241	31	40	.053
Pathological grade
I‐II	59	28	31		26	33
III	43	19	24	.743	25	18	.160
T stage
T1	50	28	22		31	19
T2‐4	52	19	33	.049*	20	32	.017*
N stage
N0	59	31	28		35	24
N1‐3	43	16	27	.125	16	27	.027*
M stage
M0	99	47	52		51	48
M1	3	0	3	.247	0	3	.243
TNM stage
I‐II	71	37	34		45	26
III‐IV	31	10	21	.061	6	25	<.001**
Mortality
Survived	46	29	17		34	12
Died	56	18	38	<.001**	17	39	<.001**

^*P <. 05; **P < .005.